Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shintaro Hirata

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Modern Rheumatology|November 21, 2013
Efficacy and safety of reducing duration of infliximab infusionShunsuke Fukuyo, Kazuyoshi Saito, Kunihiro Yamaoka, et al.
Clinical and Experimental Rheumatology|September 9, 2016
Clinical, radiographic and functional efficacy of abatacept in routine care for rheumatoid arthritis patients: Abatacept Leading Trial for RA on Imaging Remission (ALTAIR) studySatoshi Kubo, Kazuhisa Nakano, Shingo Nakayamada, et al.
Modern Rheumatology|October 9, 2014
A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational studyShintaro Hirata, Wanying Li, Nadine Defranoux, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2018
Comparison of efficacy of TNF inhibitors and abatacept in patients with rheumatoid arthritis; Adjusted with propensity score matchingSatoshi Kubo, Shingo Nakayamada, Kazuhisa Nakano, et al.
Annals of the Rheumatic Diseases|August 7, 2015
Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matchingSatoshi Kubo, Shingo Nakayamada, Kazuhisa Nakano, et al.
Modern Rheumatology|December 10, 2019
5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR studyAyako Yamaguchi, Shintaro Hirata, Satoshi Kubo, et al.
Clinical and Experimental Rheumatology|November 13, 2025
Patient clustering by serum inflammatory mediators stratifies early disease-modifying antirheumatic drug-naïve rheumatoid arthritis and reveals distinct pathobiological signatures: a prospective observational cohortGenki Kidoguchi, Michinori Ishitoku, Naoya Oka, et al.
Modern Rheumatology Case Reports|May 10, 2022
Fluorodeoxyglucose-positron emission tomography/computed tomography-positive ear lesions responsive to immunosuppressive therapy in a patient with otitis media with antineutrophil cytoplasmic antibody-associated vasculitisYuki Murao, Yusuke Yoshida, Naoya Oka, et al.
Modern Rheumatology|December 27, 2007
A case of pulmonary asbestosis presenting with temporal arteritis involving multiple medium-sized vesselsShintaro Hirata, Noboru Hattori, Nobuhisa Ishikawa, et al.
Rheumatology (Oxford, England)|January 21, 2014
Effects of tofacitinib on lymphocytes in rheumatoid arthritis: relation to efficacy and infectious adverse eventsKoshiro Sonomoto, Kunihiro Yamaoka, Satoshi Kubo, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Modern Rheumatology|November 21, 2013
Efficacy and safety of reducing duration of infliximab infusionShunsuke Fukuyo, Kazuyoshi Saito, Kunihiro Yamaoka, et al.
Clinical and Experimental Rheumatology|September 9, 2016
Clinical, radiographic and functional efficacy of abatacept in routine care for rheumatoid arthritis patients: Abatacept Leading Trial for RA on Imaging Remission (ALTAIR) studySatoshi Kubo, Kazuhisa Nakano, Shingo Nakayamada, et al.
Modern Rheumatology|October 9, 2014
A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational studyShintaro Hirata, Wanying Li, Nadine Defranoux, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2018
Comparison of efficacy of TNF inhibitors and abatacept in patients with rheumatoid arthritis; Adjusted with propensity score matchingSatoshi Kubo, Shingo Nakayamada, Kazuhisa Nakano, et al.
Annals of the Rheumatic Diseases|August 7, 2015
Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matchingSatoshi Kubo, Shingo Nakayamada, Kazuhisa Nakano, et al.
Modern Rheumatology|December 10, 2019
5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR studyAyako Yamaguchi, Shintaro Hirata, Satoshi Kubo, et al.
Clinical and Experimental Rheumatology|November 13, 2025
Patient clustering by serum inflammatory mediators stratifies early disease-modifying antirheumatic drug-naïve rheumatoid arthritis and reveals distinct pathobiological signatures: a prospective observational cohortGenki Kidoguchi, Michinori Ishitoku, Naoya Oka, et al.
Modern Rheumatology Case Reports|May 10, 2022
Fluorodeoxyglucose-positron emission tomography/computed tomography-positive ear lesions responsive to immunosuppressive therapy in a patient with otitis media with antineutrophil cytoplasmic antibody-associated vasculitisYuki Murao, Yusuke Yoshida, Naoya Oka, et al.
Modern Rheumatology|December 27, 2007
A case of pulmonary asbestosis presenting with temporal arteritis involving multiple medium-sized vesselsShintaro Hirata, Noboru Hattori, Nobuhisa Ishikawa, et al.
Rheumatology (Oxford, England)|January 21, 2014
Effects of tofacitinib on lymphocytes in rheumatoid arthritis: relation to efficacy and infectious adverse eventsKoshiro Sonomoto, Kunihiro Yamaoka, Satoshi Kubo, et al.
Pageof 16